Skip to content

Enhancing the Benefits of Blueberry Polyphenols With Protein

Enhancing the Benefits of Blueberry Polyphenols With Plant and Whey Proteins

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05967897
Enrollment
19
Registered
2023-08-01
Start date
2023-03-09
Completion date
2024-06-01
Last updated
2024-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Keywords

Healthy, Adults, Blueberries, Polyphenols, Protein, Bioavailability

Brief summary

The purpose of this randomized crossover trial is determine whether acute consumption of blueberries with different proteins from plants (hemp or pea) or dairy (whey) impact the absorption of blueberry phytochemicals, which could impact the health benefits of blueberries. A secondary purpose is to understand the role that the gut microbiome may play, as well as the impact on urine polyphenol metabolites and potential implications for cardiometabolic health. Researchers will compare four arms: 1) Blueberries; 2) Blueberries + whey protein; 3) Blueberries + pea protein; and 4) Blueberries + hemp protein.

Detailed description

Polyphenols are a structurally diverse class of secondary metabolites found in plants, with numerous documented benefits for human health including, but not limited to, anti-inflammatory, antioxidative and cardiovascular-protective effects. Dietary intake of polyphenols in the United States is low in comparison to other developed countries due to low intake of fruits and vegetables. Recent studies suggest fruit and vegetable intake should be increased by incorporating those foods into snacks and mixed meals as ingredients rather than standalone food items. Presently, berries comprise 10% of the total fruit intake and 7% of the total polyphenol intake of American adults. As a versatile food ingredient, berries can easily be added to foods like smoothies and yogurts as an ingredient to increase intake. Low polyphenol intake is an issue exacerbated by poor bioavailability. Consumption does not necessarily mean that these beneficial compounds are delivered to body tissues, as evidenced by low levels of detection in blood and accumulation in the lower gastrointestinal tract after feeding. Bioavailability can be enhanced through the complexation of polyphenols with proteins, a phenomenon which occurs naturally in complex mixtures including both classes of nutrients. It has been shown that the complexation of polyphenols with proteins in cow's milk, known as a matrix effect, enhances the polyphenol stability and uptake throughout digestion. The incorporation of berries into complex food mixtures may not only be an opportunity for improved health outcomes due to increased polyphenol intake, but also an effective strategy for ensuring that consumers receive the benefits of the nutrients they consume. It is unknown whether the beneficial matrix effects observed when polyphenols interact with dairy proteins are exclusive to dairy proteins due to characteristics of high digestibility or structures which favor phenolic interaction, or if similar effects would be observed with proteins from other sources. Increasing consumer demand for alternative protein sources for reasons pertaining to human health and environmental sustainability has introduced a variety of novel plant-based proteins to the American diet, which may elicit similarly advantageous matrix effects on the bioavailability of polyphenols depending on their digestibility and structural characteristics. Understanding protein-polyphenol interactions in novel food matrices is necessary for the development of food products that promote polyphenol consumption and bioavailability with the aim to improve human health.

Interventions

DIETARY_SUPPLEMENTBlueberries

22 g freeze-dried blueberry powder mixed with water

DIETARY_SUPPLEMENTBlueberries and Whey Protein

22 g freeze-dried blueberry powder mixed with whey protein and water

DIETARY_SUPPLEMENTBlueberries and Pea Protein

22 g freeze-dried blueberry powder mixed with pea protein and water

DIETARY_SUPPLEMENTBlueberries and Hemp Protein

22 g freeze-dried blueberry powder mixed with hemp protein and water

Sponsors

United States Department of Agriculture (USDA)
CollaboratorFED
Colorado State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Aged 18 years or older

Exclusion criteria

* • Blood levels of HbA1c ≥ 6.5%, total cholesterol ≥ 240 mg/dL, LDL cholesterol ≥ 130 mg/dL, triglycerides ≥ 200 mg/dL * Are anemic (hemoglobin less than 13.5 g/dL in men and 12.0 g/dL in women) * Have an average blood pressure greater than or equal to 130/80 mmHg, or have diagnosed hypertension, hyperlipidemia, cardiovascular disease, diabetes, cancer, kidney, liver, gastrointestinal or pancreatic disease * Taking blood pressure-, lipid- or glucose-lowering, or hormone replacement medications * Are pregnant or are trying to become pregnant * Have a body mass index \< 18.5 or \> 30 kg/m2 * \>3 days/week vigorous exercise * Are not willing to maintain your normal eating/drinking and exercise habits over the duration of the study * History of smoking cigarettes in past 12 months * Binge and/or heavy drinker (\>3 drinks on any given occasion and/or \>7 drinks/week for women, and \>4 drinks on any given occasion and/or \>14 drinks/week for men) * Have allergies or contraindication to study treatments, procedures, or procedure supplies * Unable to attend study visits.

Design outcomes

Primary

MeasureTime frameDescription
Plasma polyphenol metabolitesChange from 0 hours (pre-treatment consumption) to 1 hour post-treatment consumptionPlasma polyphenol metabolite analysis using mass spectrometry

Secondary

MeasureTime frameDescription
Urine polyphenol metabolites0 hours (pre-treatment consumption) and 24 hours post-treatment consumptionUrine polyphenol metabolite analysis using mass spectrometry

Other

MeasureTime frameDescription
Aortic pressure0 hours (pre-treatment consumption) and 1, 2, 4, and 6 hours post-treatment consumptionAortic pressure parameters (systolic pressure, aortic pressure, pulse pressure)
Augmentation index0 hours (pre-treatment consumption) and 1, 2, 4, and 6 hours post-treatment consumptionAugmentation index measured via SphygmoCor Xcel
Gut microbial analysis0 hours (pre-treatment consumption) and 24 hours post-treatment consumption16S rRNA gene sequencing
Nitric oxide metabolites0 hours (pre-treatment consumption) and 1, 2, 4, 6, and 24 hours post-treatment consumptionBlood nitric oxide metabolites will be assessed using standard assays
Insulin0 hours (pre-treatment consumption) and 1, 2, 4, 6, and 24 hours post-treatment consumptionBlood insulin will be assessed using standard assays
Glucose0 hours (pre-treatment consumption) and 1, 2, 4, 6, and 24 hours post-treatment consumptionBlood glucose will be assessed using standard assays
Blood pressure0 hours (pre-treatment consumption) and 1, 2, 4, and 6 hours post-treatment consumptionBrachial blood pressure parameters (systolic, diastolic, and pulse pressure)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026